Key Takeaways Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for ...

Here is a look at Friday’s business headlines with Jane King, where she discusses Taco Bell reupping its value menu game and ...

Kroger settles an opioid lawsuit in Kentucky for $110 million. The U.S. builds a bird flu vaccine stockpile. Shanghai permits ...

Medicare has announced the expansion of coverage for Eli Lilly’s Zepbound, a breakthrough drug in the treatment of autoimmune ...

Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year. Other things ...

In-home healthcare companies need to adapt to ensure they’re able to meet the needs of patients, providers, and payers in ...

El Lilly’s blockbuster weight-loss drug Zepbound is now eligible for coverage under Medicare prescription drug plans, when ...

Adam Maeder, an analyst from Piper Sandler, has initiated a new Hold rating on Resmed (RMD).Stay Ahead of the Market:Discover outperforming ...

US intelligence finds no proof tying 'Havana syndrome' health issues to foreign actors, but 2 agencies say it's possible.

What dietary habits reduce inflammation? What snacks boost brain health? TODAY nutrition and health expert Joy Bauer stops by ...

Piper Sandler initiated coverage of ResMed (RMD) with a Neutral rating and $252 price target While there’s a lot to like about the ResMed ...

The wildfires ravaging Southern California are making no exceptions for fancy neighborhoods like the Pacific ...